Caliway Biopharmaceuticals Co (TPE:6919) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6919 Caliway Biopharmaceuticals Co Ltd TPE:6919
55 GF Score
Price NT$94.80
GF Value NT$59.00
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Caliway Biopharmaceuticals Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Caliway Biopharmaceuticals Co Valuation Rank Related Terms

TPE:6919
55GF Score
Caliway Biopharmaceuticals Co Ltd TPE:6919
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Caliway Biopharmaceuticals Co (TPE:6919) Overvalued in 2026?

Based on GuruFocus' analysis, Caliway Biopharmaceuticals Co stock appears to be overvalued. The current stock price of NT$94.80 is trading 60.7% above its estimated GF Value™ of NT$59.00. GuruFocus considers Caliway Biopharmaceuticals Co to be Significantly Overvalued.

Key valuation signals for TPE:6919:

  • Valuation Rank:
  • GF Value™: NT$59.00 vs. price of NT$94.80 (60.7% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the TPE:6919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Caliway Biopharmaceuticals Co Business Description

Address No.99, Section 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. The group has one operating segment, which is Healthy Food, and others.
55GF Score

Get the complete analysis for TPE:6919

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$94.80
Price
NT$59.00
GF Value